Mustang Bio Statistics
Total Valuation
Mustang Bio has a market cap or net worth of $5.08 million. The enterprise value is -$12.42 million.
Important Dates
The last earnings date was Thursday, March 19, 2026, after market close.
| Earnings Date | Mar 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mustang Bio has 6.73 million shares outstanding. The number of shares has increased by 705.02% in one year.
| Current Share Class | 6.45M |
| Shares Outstanding | 6.73M |
| Shares Change (YoY) | +705.02% |
| Shares Change (QoQ) | +3.68% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 20.16% |
| Float | 5.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.13 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.22
| Current Ratio | 2.22 |
| Quick Ratio | 2.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.93% and return on invested capital (ROIC) is -46.53%.
| Return on Equity (ROE) | -67.93% |
| Return on Assets (ROA) | -11.30% |
| Return on Invested Capital (ROIC) | -46.53% |
| Return on Capital Employed (ROCE) | -25.13% |
| Weighted Average Cost of Capital (WACC) | 16.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$320,167 |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.50% in the last 52 weeks. The beta is 2.14, so Mustang Bio's price volatility has been higher than the market average.
| Beta (5Y) | 2.14 |
| 52-Week Price Change | -46.50% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 1.34 |
| Relative Strength Index (RSI) | 26.77 |
| Average Volume (20 Days) | 36,743 |
Short Selling Information
The latest short interest is 84,718, so 1.26% of the outstanding shares have been sold short.
| Short Interest | 84,718 |
| Short Previous Month | 133,993 |
| Short % of Shares Out | 1.26% |
| Short % of Float | 1.67% |
| Short Ratio (days to cover) | 2.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.43M |
| Pretax Income | -1.92M |
| Net Income | -1.92M |
| EBITDA | -2.40M |
| EBIT | -2.43M |
| Earnings Per Share (EPS) | -$0.39 |
Full Income StatementBalance Sheet
The company has $17.27 million in cash and n/a in debt, with a net cash position of $17.27 million or $2.56 per share.
| Cash & Cash Equivalents | 17.27M |
| Total Debt | n/a |
| Net Cash | 17.27M |
| Net Cash Per Share | $2.56 |
| Equity (Book Value) | 9.53M |
| Book Value Per Share | 5.64 |
| Working Capital | 9.68M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.26M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 34,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.26M |
| FCF Per Share | -$0.78 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
